ePRO/eCOA Featured Articles

1. Dear Data Analysts, AI Is Not Replacing You 4/2/2024

   Deep beneath the ongoing narrative of AI’s potential use cases in clinical trials is the same fear that persists in other industries facing this technology revolution. Namely, will jobs be lost and replaced by machines? So, I thought I’d ask an expert — a machine.

2. 3 Tips For Selecting Your eTMF Platform 3/7/2024

   Each eTMF platform presents its own set of advantages and drawbacks. Be sure to incorporate these three tips when considering a new eTMF vendor and its services.

3. Increasing The Usefulness Of PROs In Oncology Research 2/20/2024

   Dr. Anthony Everhart (Clinical VP, Internal Medicine, Signant Health) and Tim Meyer (Professor, Experimental Cancer Medicine, University College London) discuss opportunities for increasing the usefulness of PROMs.

4. Can We Break The Digital Barrier In Clinical Trials? 1/22/2024

   In a recent episode of Clinical Leader Live, a panel of experts explore the barriers and benefits of leveraging technology in clinical trials.

5. Enhancing Clinical Trial Efficiency & Compliance With eQMS 1/10/2024

   In recent years, electronic quality management systems (eQMS) have emerged as powerful tools to streamline and enhance the quality control processes in clinical trials. This article explores the key components, benefits, challenges, and future of eQMS in the context of clinical trials.

6. How Can Electronic Data Capture Better Serve Decentralized Clinical Trials? 11/15/2023

   Newer, nimbler technology providers face a steep climb if they want to convince sponsors to sunset traditional EDC in favor of direct data capture only, or a unified decentralized trial platform that everything plugs into. Will EDC evolve to fix its existing problems, or will a different type of decentralized trial platform (or single platform model) replace pick-and-pull, add-and-subtract modules of clinical trial technology?

7. Electronic Data Capture In Clinical Trials: What Needs To Improve? 11/14/2023

   Integrated technologies enhance clinical trial support, boosting the potential for quicker time-to-market. Key sponsors and CROs favoring operational efficiency prioritize "holistic study design," involving the integration of technologies (e.g., EDC, eCOA, and IRT) aligned with protocol, as opposed to constructing the study in individual tools.

8. Regulatory Guidance For PRO Strategy In Oncology Trials 11/10/2023

   Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

9. The Dos and Don’ts Of Patient Centricity 8/15/2023

   New, exciting methodologies like DCTs and wearables can improve patient centricity, but only when participants’ lifestyles and preferences are kept in mind.

10. Implementing New Technology: Is Change Always Good? 8/9/2023

    New clinical trial technologies promise increased ROI but gaining buy-in from sites and staff, managing the transition, and anticipating the next big leap in technology present many challenges.